A Disease Register for ME/CFS: Report of a Pilot Study.
Pheby, Derek, Lacerda, Eliana, Nacul, Luis et al. · BMC research notes · 2011 · DOI
Quick Summary
Researchers created a disease register (a database) to identify and track people with ME/CFS in a fair and systematic way. They searched GP records in three regions of England and found 510 patients with unexplained chronic fatigue, of which 160 agreed to join the register. By following these patients over time, researchers can better understand how ME/CFS progresses and use this group for future studies.
Why It Matters
This study demonstrates a practical method for systematically identifying ME/CFS patients from primary care databases, solving a major research challenge of recruiting representative populations. Having a well-characterized disease register and long-term cohort enables future research to answer questions about prognosis, natural history, and disease mechanisms in ME/CFS.
Observed Findings
510 patients with unexplained chronic fatigue were identified from GP databases across three regions
265 patients (52%) met one or more ME/CFS case definitions
160 patients (31% of identified) consented to join the disease register
96.9% of register participants met the CDC 1994 (Fukuda) case definition
One-year follow-up showed little change in pain and fatigue scores, though some patients changed case definition status
Inferred Conclusions
The disease register approach successfully recruited an unbiased cohort of ME/CFS patients suitable for long-term follow-up and as a sampling frame for other studies
Multiple case definitions can be applied to the same population, with the Canadian definition identifying a more homogeneous subset than the CDC definition
The systematic approach to case identification, data management, and analysis is feasible and can be expanded to larger geographic areas
Remaining Questions
What are the long-term prognosis and prognostic factors in ME/CFS beyond one year of follow-up?
How representative are the disease register participants of the total ME/CFS population, including undiagnosed cases and specialist-only patients?
What This Study Does Not Prove
This pilot study does not establish the causes of ME/CFS, does not prove prognosis or long-term outcomes (follow-up was limited to one year with only 50 subjects), and does not demonstrate comprehensive population coverage. The findings apply mainly to diagnosed patients in primary care and may not represent undiagnosed cases or those in specialist care.
Tags
Symptom:PainFatigue
Method Flag:Weak Case DefinitionSmall SampleExploratory Only